Related Experiment Video

Updated: Jun 10, 2026

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

Interleukin 2 in cancer therapy

G K Antony1, A Z Dudek

  • 1Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA.

Current Medicinal Chemistry
|August 18, 2010
PubMed

Insights

Interleukin-2 (IL-2) immunotherapy offers long-term control for advanced cancers like melanoma and renal cell carcinoma. Future cancer treatments may combine IL-2 with novel therapies to enhance efficacy and manage toxicity.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Interleukin-2 (IL-2) is an established immunotherapy for advanced cancers.
  • IL-2 has shown long-term disease control in metastatic renal cell carcinoma and malignant melanoma.
  • Emerging cancer therapies include kinase inhibitors, immunomodulatory molecules, cytokines, and vaccines.

Purpose of the Study:

  • To review the established activity and toxicity of IL-2 in advanced malignancies.
  • To explore the potential of combining IL-2 with novel cancer therapeutic strategies.
  • To speculate on the future applications of IL-2 in cancer treatment.

Main Methods:

  • Literature review of IL-2 efficacy and toxicity in cancer.
  • Analysis of current trends in cancer immunotherapy development.
  • Discussion of potential combination strategies involving IL-2.

Main Results:

  • IL-2 demonstrates significant activity in specific advanced malignancies.
  • Novel therapies are being developed for cancer treatment.
  • Combining IL-2 with other agents is a growing area of interest.

Conclusions:

  • IL-2 remains a valuable agent in managing advanced cancers.
  • Future cancer immunotherapy may involve synergistic combinations with IL-2.
  • Careful consideration of toxicity is crucial when integrating IL-2 into novel treatment regimens.

More Related Videos

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...